| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Intellia Therapeutics, Inc. (NTLA) has 12 insiders with recent SEC Form 4 filings, including 7 buys and 0 sells. NTLA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.01M | $15.88M | - | |
| Dir | 207.5K | $3.25M | - | |
| Dir | 134.7K | $2.11M | - | |
| VP | 121.2K | $1.90M | - | |
| VP | 101.5K | $1.59M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 11, 2016 | Baker Bros. Advisors LP59 | Former 10% Owner | Buy | 200,000 | $18.00 | $3,600,000.00 | +23.2% | |
| May 11, 2016 | Orbimed Advisors LLC67 | Director | Buy | 250,000 | $18.00 | $4,500,000.00 | +5.0% | |
| May 11, 2016 | Temasek Holdings (private) Ltd46 | 10% Owner | Buy | 300,000 | $18.00 | $5,400,000.00 | +61.2% | |
| May 11, 2016 | Gordon Carl L74 | Director | Buy | 250,000 | $18.00 | $4,500,000.00 | +5.0% |